Now showing items 1-1 of 1

    • Thioredoxin Downregulation Enhances Sorafenib Effects in Hepatocarcinoma Cells 

      López-Grueso, María José; González, Raúl; Muntané Relat, Jordi; Bárcena, J.A.; Padilla, Alicia (MDPI, 2019)
      Sorafenib is the first-line recommended therapy for patients with advanced hepatocarcinoma (HCC) in de-differentiation stage (presenting epithelial–mesenchymal transition, EMT). We studied the role of the thioredoxin system ...